Table 4.
Comparison of the clinical characteristics of patients with atrial fibrillation aged ≥75 years treated with either a vitamin K antagonist (VKA) or a non-vitamin K antagonist oral anticoagulant (NOAC).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.